Is there a role for minimal residual disease monitoring in the management of patients with hairy-cell leukaemia?

Authors :: Ortiz-Maldonado V
Villamor N
Baumann T
Aymerich M
Magnano L
Mozas P
Rivas-Delgado A
Martínez-Trillos A
Giné E
Campo E
López-Guillermo A
Delgado J
Source :: British journal of haematology [Br J Haematol] 2018 Oct; Vol. 183 (1), pp. 127-129. Date of Electronic Publication: 2017 Aug 18.
Publication Year :: 2018

Subjects :: Adult
Aged
Cladribine therapeutic use
Disease Management
Female
Humans
Immunophenotyping methods
Male
Middle Aged
Pentostatin therapeutic use
Purines therapeutic use
Rituximab therapeutic use
Leukemia, Hairy Cell pathology
Neoplasm, Residual diagnosis

Full Text Access

Tools